A citation-based method for searching scientific literature


List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree, Dominique Figarella-Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger,[...]. Neuro Oncol 2021
100

Survival Outcomes and Prognostic Factors in Glioblastoma.
Nicholas F Brown, Diego Ottaviani, John Tazare, John Gregson, Neil Kitchen, Sebastian Brandner, Naomi Fersht, Paul Mulholland. Cancers (Basel) 2022
4
100

Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.
Stefanie Bette, Melanie Barz, Benedikt Wiestler, Thomas Huber, Julia Gerhardt, Niels Buchmann, Stephanie E Combs, Friederike Schmidt-Graf, Claire Delbridge, Claus Zimmer,[...]. Ann Surg Oncol 2018
20
66

Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation.
Daniele Armocida, Alessandro Frati, Maurizio Salvati, Antonio Santoro, Alessandro Pesce. Clin Neurol Neurosurg 2020
19
66

CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Romain Appay, Caroline Dehais, Claude-Alain Maurage, Agusti Alentorn, Catherine Carpentier, Carole Colin, François Ducray, Fabienne Escande, Ahmed Idbaih, Aurélie Kamoun,[...]. Neuro Oncol 2019
71
66

Clinical practice guidelines for the management of adult diffuse gliomas.
Tao Jiang, Do-Hyun Nam, Zvi Ram, Wai-Sang Poon, Jiguang Wang, Damdindorj Boldbaatar, Ying Mao, Wenbin Ma, Qing Mao, Yongping You,[...]. Cancer Lett 2021
100
66

Prognostic and Predictive Biomarkers in Gliomas.
Paulina Śledzińska, Marek G Bebyn, Jacek Furtak, Janusz Kowalewski, Marzena A Lewandowska. Int J Mol Sci 2021
24
33

Genetic and epigenetic contribution to astrocytic gliomas pathogenesis.
Pouria Khani, Farzad Nasri, Fateme Khani Chamani, Farzane Saeidi, Javid Sadri Nahand, Alireza Tabibkhooei, Hamed Mirzaei. J Neurochem 2019
67
33

The SHORT Score for Preoperative Assessment of the Risk for Short-Term Survival in Glioblastoma.
Daniela Pierscianek, Yahya Ahmadipour, Klaus Kaier, Marvin Darkwah Oppong, Anna Michel, Sied Kebir, Martin Stuschke, Martin Glas, Ulrich Sure, Ramazan Jabbarli. World Neurosurg 2020
4
33

Diagnosis and Management of Glioblastoma: A Comprehensive Perspective.
Vianney Gilard, Abdellah Tebani, Ivana Dabaj, Annie Laquerrière, Maxime Fontanilles, Stéphane Derrey, Stéphane Marret, Soumeya Bekri. J Pers Med 2021
7
33

Adult low-grade glioma: 19-year experience at a single institution.
Ryan S Youland, Paul D Brown, Caterina Giannini, Ian F Parney, Joon H Uhm, Nadia N Laack. Am J Clin Oncol 2013
37
33



An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program.
Gonçalo Forjaz, Jill S Barnholtz-Sloan, Carol Kruchko, Rebecca Siegel, Serban Negoita, Quinn T Ostrom, Lois Dickie, Jennifer Ruhl, Alison Van Dyke, Nirav Patil,[...]. Neurooncol Adv 2020
9
33

Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Soma Ghasimi, Carl Wibom, Anna M Dahlin, Thomas Brännström, Irina Golovleva, Ulrika Andersson, Beatrice Melin. J Neurooncol 2016
26
33


Newly Diagnosed Glioblastoma: A Review on Clinical Management.
Rimas V Lukas, Derek A Wainwright, Erik Ladomersky, Sean Sachdev, Adam M Sonabend, Roger Stupp. Oncology (Williston Park) 2019
58
33

Prognostic role of Ki-67 in glioblastomas excluding contribution from non-neoplastic cells.
Rikke H Dahlrot, Julie A Bangsø, Jeanette K Petersen, Ann Mari Rosager, Mia D Sørensen, Guido Reifenberger, Steinbjørn Hansen, Bjarne W Kristensen. Sci Rep 2021
6
33

IDH Mutations in Glioma: Double-Edged Sword in Clinical Applications?
Alisan Kayabolen, Ebru Yilmaz, Tugba Bagci-Onder. Biomedicines 2021
11
33

Brain Tumours: Rise in Glioblastoma Multiforme Incidence in England 1995-2015 Suggests an Adverse Environmental or Lifestyle Factor.
Alasdair Philips, Denis L Henshaw, Graham Lamburn, Michael J O'Carroll. J Environ Public Health 2018
80
33

Expression of Olig2, Nestin, NogoA and AQP4 have no impact on overall survival in IDH-wildtype glioblastoma.
Felix Behling, Alonso Barrantes-Freer, Carl Ludwig Behnes, Florian Stockhammer, Veit Rohde, Antonia Adel-Horowski, Odir Antonio Rodríguez-Villagra, Miguel Angel Barboza, Wolfgang Brück, Ulrich Lehmann,[...]. PLoS One 2020
5
33

Seizure characteristics and prognostic factors of gliomas.
Melissa Kerkhof, Charles J Vecht. Epilepsia 2013
128
33


Suppression of Nestin reveals a critical role for p38-EGFR pathway in neural progenitor cell proliferation.
Wentao Hu, Hong Lu, Shang Wang, Wenhan Yin, Xujie Liu, Lin Dong, Richard Chiu, Li Shen, Wen-Jing Lu, Feng Lan. Oncotarget 2016
12
33


Disparities in glioblastoma survival by case volume: a nationwide observational study.
Rahul Raj, Karri Seppä, Tapio Luostarinen, Nea Malila, Matti Seppälä, Janne Pitkäniemi, Miikka Korja. J Neurooncol 2020
7
33

The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group.
Prakash Chinnaiyan, Meihua Wang, Amyn M Rojiani, Philip J Tofilon, Arnab Chakravarti, K Kian Ang, Hua-Zhong Zhang, Elizabeth Hammond, Walter Curran, Minesh P Mehta. Radiat Oncol 2008
37
33

Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment
Farina Hanif, Kanza Muzaffar, Kahkashan Perveen, Saima M Malhi, Shabana U Simjee. Asian Pac J Cancer Prev 2017
414
33


Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
Karina Biserova, Arvids Jakovlevs, Romans Uljanovs, Ilze Strumfa. Cells 2021
30
33

Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients.
M P W A Houben, W J Louwman, C C Tijssen, J L J M Teepen, C M Van Duijn, J W W Coebergh. Ann Oncol 2004
16
33

Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Yu-Qing Liu, Fan Wu, Jing-Jun Li, Yang-Fang Li, Xing Liu, Zheng Wang, Rui-Chao Chai. Front Oncol 2019
10
33

Relationship between cognitive function and prognosis in glioblastoma.
Derek R Johnson, Jeffrey S Wefel. CNS Oncol 2013
14
33


The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas.
Kyung-Jung Kim, Kyung-Hwa Lee, Hyung-Seok Kim, Kyung-Sub Moon, Tae-Young Jung, Shin Jung, Min-Cheol Lee. Neuropathology 2011
65
33


Adult Glioblastoma.
Brian M Alexander, Timothy F Cloughesy. J Clin Oncol 2017
361
33

Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival.
Severina Leu, Jean-Louis Boulay, Sarah Thommen, Heiner C Bucher, Christoph Stippich, Luigi Mariani, Andrea Bink. World Neurosurg 2018
10
33

The cIMPACT-NOW updates and their significance to current neuro-oncology practice.
L Nicolas Gonzalez Castro, Pieter Wesseling. Neurooncol Pract 2020
24
33

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
J J Jacobs, P Keblusek, E Robanus-Maandag, P Kristel, M Lingbeek, P M Nederlof, T van Welsem, M J van de Vijver, E Y Koh, G Q Daley,[...]. Nat Genet 2000
306
33

Nestin expression--a property of multi-lineage progenitor cells?
C Wiese, A Rolletschek, G Kania, P Blyszczuk, K V Tarasov, Y Tarasova, R P Wersto, K R Boheler, A M Wobus. Cell Mol Life Sci 2004
503
33

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
33

National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States.
Quinn T Ostrom, Madison L Shoaf, Gino Cioffi, Kristin Waite, Carol Kruchko, Patrick Y Wen, Daniel Brat, Jill S Barnholtz-Sloan, J Bryan Iorgulescu. Neuro Oncol 2022
1
100

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
33

cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC).
David N Louis, Pieter Wesseling, Werner Paulus, Caterina Giannini, Tracy T Batchelor, J Gregory Cairncross, David Capper, Dominique Figarella-Branger, M Beatriz Lopes, Wolfgang Wick,[...]. Acta Neuropathol 2018
83
33

Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomas.
Yao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, Stephanie Hilz, David A Solomon, Serah Choi, Michael Wahl, Tali Mazor, Chibo Hong, Anny Shai,[...]. Neuro Oncol 2021
22
33

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Quinn T Ostrom, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2021
257
33

Radiomics and radiogenomics in gliomas: a contemporary update.
Gagandeep Singh, Sunil Manjila, Nicole Sakla, Alan True, Amr H Wardeh, Niha Beig, Anatoliy Vaysberg, John Matthews, Prateek Prasanna, Vadim Spektor. Br J Cancer 2021
40
33

Tumor location-based classification of surgery-related language impairments in patients with glioma.
Shengyu Fang, Yuchao Liang, Lianwang Li, Lei Wang, Xing Fan, Yinyan Wang, Tao Jiang. J Neurooncol 2021
4
33

Advances in the Surgical Management of Low-Grade Glioma.
Todd Hollon, Shawn L Hervey-Jumper, Oren Sagher, Daniel A Orringer. Semin Radiat Oncol 2015
26
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.